(Stroke. 1997;28:387-391.)
© 1997 American Heart Association, Inc.
Articles |
Medical Therapy for Intracerebral Hematoma With the 
-Aminobutyric Acid-A Agonist Muscimol
the Neurology and Research Services of the San Diego Veterans Administration Medical Center and the Department of Neurosciences, University of California, San Diego.
Correspondence to Dr Patrick D. Lyden, Neurology Service (127), 3350 La Jolla Village Dr, San Diego, CA 92161.
Background and Purpose No therapy has been rigorously proven effective for intracerebral hematoma, although surgery is frequently used for some types of lobar hemorrhages. Since intracerebral mass causes significant ischemia in surrounding brain, we reasoned that anti-ischemia therapy might improve outcome after experimental hematoma.
Methods We stereotaxically injected varying doses of bacterial collagenase into the caudate nucleus of rats. Four hours later we administered intravenously 2 mg/kg muscimol, a potent agonist of the -aminobutyric acid-A receptor (n=20); 1 mg/kg MK-801, an antagonist of the N-methyl-D-aspartate receptor (n=17); or saline (n=28). Forty-eight hours after collagenase injection we rated each animal using a standard rodent neurological examination. The ratings were compared with the amounts of injected collagenase by the quantal bioassay procedure. Brains were then prepared for histomorphometry and brain volumes estimated.
Results We found that the ED50 for collagenase (amount of enzyme that renders 50% of the subjects abnormal) was 0.77±0.09 U in saline-treated subjects. Treatment with muscimol significantly increased the ED50 to 1.2±0.21 U, for a potency ratio of 1.55±0.34 (t=1.7, P<.05). MK-801 did not affect outcome. Volume of hematoma was significantly correlated with amount of injected collagenase (n=33, r=.64, P<.001). Volumes of basal ganglia and white matter were significantly reduced by hemorrhage, and muscimol partially ameliorated this.
Conclusions We conclude that muscimol significantly improves neurological outcome after intracerebral hematoma.
Editorial Comment
Department of NeurosurgeryWayne State UniversityDetroit, Mich
This article has been cited by other articles:
 |
|
 |
|
  NINDS ICH Workshop Participants Priorities for Clinical Research in Intracerebral Hemorrhage: Report From a National Institute of Neurological Disorders and Stroke Workshop Stroke, March 1, 2005; 36(3): e23 - e41. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. D. Ardizzone, A. Lu, K. R. Wagner, Y. Tang, R. Ran, and F. R. Sharp Glutamate Receptor Blockade Attenuates Glucose Hypermetabolism in Perihematomal Brain After Experimental Intracerebral Hemorrhage in Rat Stroke, November 1, 2004; 35(11): 2587 - 2591. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Castillo, A. Davalos, J. Alvarez-Sabin, J. M. Pumar, R. Leira, Y. Silva, J. Montaner, and C.S. Kase Molecular signatures of brain injury after intracerebral hemorrhage Neurology, February 26, 2002; 58(4): 624 - 629. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. S. Kidwell, J. L. Saver, J. Mattiello, S. Warach, D. S. Liebeskind, S. Starkman, P. M. Vespa, J. P. Villablanca, N. A. Martin, J. Frazee, et al. Diffusion-perfusion MR evaluation of perihematomal injury in hyperacute intracerebral hemorrhage Neurology, November 13, 2001; 57(9): 1611 - 1617. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Lyden, C. Shin, C. Jackson-Friedman, S. Hassid, A. Chong, and R. L. Macdonald Effect of Ganaxolone in a Rodent Model of Cerebral Hematoma Editorial Comment Stroke, January 1, 2000; 31(1): 169 - 175. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Clark, L. Gunion-Rinker, N. Lessov, K. Hazel, and R. L. Macdonald Citicoline Treatment for Experimental Intracerebral Hemorrhage in Mice • Editorial Comment Stroke, October 1, 1998; 29(10): 2136 - 2140. [Abstract] [Full Text] [PDF]
|
|